Gennari L, Merlotti D, Martini G, Nuti R (September 2006). "Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis". Expert Opinion on Investigational Drugs. 15 (9): 1091–103. doi:10.1517/13543784.15.9.1091. PMID16916275. S2CID20693299.
Gennari L (June 2006). "Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis". Drugs of Today. 42 (6): 355–67. doi:10.1358/dot.2006.42.6.973583. PMID16845439.
Gennari L (September 2009). "Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy". Expert Opinion on Pharmacotherapy. 10 (13): 2209–20. doi:10.1517/14656560903127241. PMID19640205. S2CID21020484.
Lednicer D, Emmert DE, Lyster SC, Duncan GW (September 1969). "Mammalian antifertility agents. VI. A novel sequence for the preparation of 1,2-disubstituted 3,4-dihydronaphthalenes". Journal of Medicinal Chemistry. 12 (5): 881–5. doi:10.1021/jm00305a038. PMID5812203.
Gennari L, Merlotti D, Martini G, Nuti R (September 2006). "Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis". Expert Opinion on Investigational Drugs. 15 (9): 1091–103. doi:10.1517/13543784.15.9.1091. PMID16916275. S2CID20693299.
Gennari L (June 2006). "Lasofoxifene: a new type of selective estrogen receptor modulator for the treatment of osteoporosis". Drugs of Today. 42 (6): 355–67. doi:10.1358/dot.2006.42.6.973583. PMID16845439.
Gennari L (September 2009). "Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy". Expert Opinion on Pharmacotherapy. 10 (13): 2209–20. doi:10.1517/14656560903127241. PMID19640205. S2CID21020484.
Lednicer D, Emmert DE, Lyster SC, Duncan GW (September 1969). "Mammalian antifertility agents. VI. A novel sequence for the preparation of 1,2-disubstituted 3,4-dihydronaphthalenes". Journal of Medicinal Chemistry. 12 (5): 881–5. doi:10.1021/jm00305a038. PMID5812203.
Gennari L, Merlotti D, Martini G, Nuti R (September 2006). "Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis". Expert Opinion on Investigational Drugs. 15 (9): 1091–103. doi:10.1517/13543784.15.9.1091. PMID16916275. S2CID20693299.
Gennari L (September 2009). "Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy". Expert Opinion on Pharmacotherapy. 10 (13): 2209–20. doi:10.1517/14656560903127241. PMID19640205. S2CID21020484.